Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.
Saved in:
| Title: | Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation. |
|---|---|
| Authors: | Carson C; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Raman P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Tullai J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Xu L; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Henault M; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Thomas E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Yeola S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Lao J; Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America., McPate M; Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Verkuyl JM; Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Marsh G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Sarber J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Amaral A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Bailey S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Lubicka D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Pham H; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Miranda N; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Ding J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Tang HM; Novartis Institutes for Biomedical Research, East Hanover, New Jersey, United States of America., Ju H; Novartis Institutes for Biomedical Research, East Hanover, New Jersey, United States of America., Tranter P; Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Ji N; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Krastel P; Novartis Institutes for Biomedical Research, Basel, Switzerland., Jain RK; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Schumacher AM; Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America., Loureiro JJ; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., George E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Berellini G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Ross NT; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Bushell SM; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Erdemli G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Solomon JM; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America. |
| Source: | PloS one [PLoS One] 2015 Jun 22; Vol. 10 (6), pp. e0127498. Date of Electronic Publication: 2015 Jun 22 (Print Publication: 2015). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
